Ebola virus (EBOV) infection: Therapeutic strategies

This publication has 82 references indexed in Scilit:

• Ebola Vaccination: If Not Now, When?
  Annals of Internal Medicine, 2014
• The 2014 Ebola virus disease outbreak in West Africa
  Journal of General Virology, 2014
• The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry
  Journal of Antimicrobial Chemotherapy, 2014
• Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model
  Antiviral Research, 2014
• Activity of and Effect of Subcutaneous Treatment with the Broad-Spectrum Antiviral Lectin Griffithsin in Two Laboratory Rodent Models
  Antimicrobial Agents and Chemotherapy, 2014
• Antibodies are necessary for rVSV/ZEBOV-GP–mediated protection against lethal Ebola virus challenge in nonhuman primates
  Proceedings of the National Academy of Sciences, 2013
• Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5
  Nature Immunology, 2011
• Inhibition of heat-shock protein 90 reduces Ebola virus replication
  Antiviral Research, 2010
• Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice
  Antimicrobial Agents and Chemotherapy, 2009
• Targeting glycosylation as a therapeutic approach
  Nature Reviews Drug Discovery, 2002